» Articles » PMID: 17363565

Destabilized Adhesion in the Gastric Proliferative Zone and C-Src Kinase Activation Mark the Development of Early Diffuse Gastric Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 2007 Mar 17
PMID 17363565
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The initial development of diffuse gastric cancer (DGC) is poorly understood. The study of E-cadherin (CDH1) germ line mutation carriers predisposed to DGC provides a rare opportunity to elucidate the genetic and biological events surrounding disease initiation. Samples from various stages of hereditary and sporadic DGC were investigated to determine general mechanisms underlying early DGC development. Paraffin-embedded tissues from 13 CDH1 mutation carriers and from 10 sporadic early DGC cases were analyzed. Immunofluorescence and immunohistochemistry using differentiation, proliferation, and adhesion markers showed that DGC initiation seems to occur at the proliferative zone (the upper neck) of the gastric epithelium and correlates with absent or reduced expression of junctional proteins (beta-actin, p120, Lin-7). Slow proliferation of neoplastic cells at the upper gastric neck leads to the formation of intramucosal signet-ring cell carcinoma (SRCC) displaying differentiated features. As shown by immunolabeling, invasion from SRCC lesions beyond the gastric mucosa is associated with poor differentiation, increased proliferation, activation of the c-Src system, and an epithelial-mesenchymal transition. Our results provide a molecular description of the early development of DGC and explain the relationship between the two main DGC types, poorly differentiated carcinoma and SRCC: both share their origin, but SRCC develops following cancer cell differentiation and seems relatively indolent in its intramucosal stage.

Citing Articles

Current advances and challenges in Managing Hereditary Diffuse Gastric Cancer (HDGC): a narrative review.

van der Sluis L, van Dieren J, van der Post R, Bisseling T Hered Cancer Clin Pract. 2024; 22(1):21.

PMID: 39379994 PMC: 11462652. DOI: 10.1186/s13053-024-00293-5.


Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics.

Wu L, Jang S, Shapiro C, Fazlollahi L, Wang T, Ryeom S Target Oncol. 2024; 19(6):845-865.

PMID: 39271577 PMC: 11557641. DOI: 10.1007/s11523-024-01097-2.


CDH1 gene mutation, a challenging surgical topic: Case report and literature review.

Maalouf H, Saber T, Ghattas S, Meguerian-Bedoyan Z, El Rassi Z Int J Surg Case Rep. 2024; 116:109422.

PMID: 38394940 PMC: 10943988. DOI: 10.1016/j.ijscr.2024.109422.


Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular Breast Cancer.

Giunta E, Arrichiello G, Pappalardo A, Federico P, Petrillo A Cancer Treat Res. 2024; 188:89-104.

PMID: 38175343 DOI: 10.1007/978-3-031-33602-7_4.


Decoding the basis of histological variation in human cancer.

Fujii M, Sekine S, Sato T Nat Rev Cancer. 2023; 24(2):141-158.

PMID: 38135758 DOI: 10.1038/s41568-023-00648-5.